Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2021

May 24, 2021

30016_dirs_2021-05-24_35bc56da-8323-4442-80a7-8f924949861d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-05-20

Reporting Person: Turner Kathy V (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-20 Common Stock S 1000 $535 Disposed 9766 Direct
2021-05-20 Common Stock S 1000 $540 Disposed 8766 Direct
2021-05-21 Common Stock S 1000 $545 Disposed 7766 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 100 Indirect

Footnotes

F1: Includes 12 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021.

F2: The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.